ADS Clinical Orals: Type 1 Diabetes — ASN Events
11:00AM - 1:00PM
Room L3
Chairs: Jane Holmes-Walker & Jennifer Conn

A combination of 15 SNPs and clinical features in relatives with islet autoantibodies improves prediction of Type 1 Diabetes: implications for prevention trials. (#43)

11:00 AM
John M Wentworth

A Feasibility Study of a Novel Redundant Electrochemical Sensor for Continuous Glucose Monitoring in Patients With Type 1 Diabetes (Tid) (#44)

11:15 AM
Dilshani Jayawardene

The Performance of an Orthogonally Redundant Glucose Sensor compared to a Simply Redundant Electrochemical Glucose Sensor in Adults with Type 1 Diabetes (#45)

11:30 AM
Sybil A McAuley

LY2963016 Insulin Glargine (LY IGlar) Compared with Lantus® Insulin Glargine (IGlar) in Patients with Type 1 Diabetes Mellitus (T1DM): Efficacy, Safety, and Patient-reported Outcomes from the ELEMENT-1 Study (#46)

11:45 AM
Julio Rosenstock

Metabolic syndrome in type 1 diabetes: exploring the prevalence of ‘double diabetes’ and the risk of diabetes complications in the Australian National Diabetes Information Audit and Benchmarking (ANDIAB) Initiative (#47)

12:00 PM
Angela S Lee

Mortality in Type 1 Diabetes is Increased in the Presence of the Metabolic Syndrome, but Remains Lower than in Young Onset Type 2 Diabetes (#48)

12:15 PM
Jencia Wong

Diabetic Ketoacidosis in Adult Patients – An audit of factors influencing time to normalisation of metabolic parameters. (#49)

12:30 PM
Melissa H Lee

Creatinine is Falsely Elevated in Diabetic Ketoacidosis Patients: A Comparison of 4 Jaffe Assays with an Enzymatic Method. (#50)

12:45 PM
Azni Abdul-Wahab